Clinical Trial Update: A Trial to Learn How Safe AZD9550 Monotherapy and Combined With AZD6234 is in People With or Without Type 2 Diabetes Who Are Living With Obesity and Overweight [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update from AstraZeneca describes a Phase 1/2 study evaluating AZD9550 alone and in combination with AZD6234 in adults with overweight/obesi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• AZD6234
• AZD9550

Snippet

Sponsor: AstraZeneca | Conditions: Overweight and Obesity | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING